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Epstein-Barr Virus (EBV) infection 
presents with diverse clinical 
manifestations along a broad 
spectrum of disease severity.
The classic triad of EBV 
infection is fever, pharyngitis, 
and lymphadenopathy.  Acute 
EBV infection may also 
manifest as hemolytic anemia, 
granulocytopenia, encephalitis, 
pericarditis, hepatitis, and other 
solid organ involvement.1
First described in 1889, Acute 
renal failure from EBV-infectious 
mononucleosis is a rare disease 
complication, but subtle 
abnormalities in urinalysis, such 
as hematuria and proteinuria have 
been noted in as many as 15% of 
patients.1
Renal involvement of EBV 
typically includes a focal interstial 
mononuclear infiltrate. Glomerular 
involvement is uncommon, though 
both minimal change lesions2 as 
well as mesangiolysis have been 
reported.3
The diagnosis of EBV involvement in 
the kidney has been demonstrated 
using both in situ hybridization1,2 as 
well as PCR assays.3  
The pathogenesis of EBV induced 
renal involvement and its rare 
occurrence remain unclear. 
T-cell activation, and direct injury 
due to EBV have been proposed 
mechanisms of renal injury.4
Case Presentation
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TABLE 1.  Initial Laboratory Data
 Hematology Value Chemistry Value
WBC (thou/cmm) 14 Sodium (mEq/L) 136
Neutrophil 41% Potassium (mEq/L) 3.7
Lymphocyte 5% BUN (mg/dL) 25
Monocyte 4% Creatinine (mg/dL) 2.34
Bands 11% Lactate (mm0l/L) 0.7
Reactive Lymphocytes 39% CO2 (mEq/L) 22
ALT (U/L) 70
Hgb (g/dL) 14.5 AST (U/L) 70
CK (U/L) 117
Blood Cultures Negative
Urine Value Serology Value
Specific Gravity 1.02 EBV VCA IgG 0.70 (<0.91)
pH 6 EBV VCA IgM 1.68 (<0.91)
Protein (mg/dL) 300-600 Monospot Positive (Neg)
Blood (mg/dL) 0.03 ASO 947 (<240)
RBC (per hpf) 3 to 5 Mycoplasma IgM 1.27 (<0.91)
WBC (per hpf) 6 to 10 Mycoplasma IgG 4.11 (<0.91)
Granular Casts (per lpf) >10 HIV Neg
Leptospirosis Neg
Protein: Creatinine ratio 2.34 Resp Viral PCR Neg





Shows light microscopic findings. There is a moderately severe 
lymphocytic interstitial infiltrate. Eosinophils are minimal.  There 
are associated patchy foci of active lymphocytic tubulitis, necrotic 
tubules with neutrophils and many tubules with granular cell casts, 
suggestive of ATN.
Figure 2B.
Shows direct immunofluorescence using antibodies to CD20, CD3, 
CD4, and CD8. The infiltrate is predominately  CD4 T-helper cells 
(CD4:CD8 ratio around 4:1) However, there is virtually absent CD20 
positive B lymphocytes among lymphoid infiltrate.
Figure 1.
Patient’s serum creatinine during hospitalization.  Renal biopsy 
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A previously healthy, 21-year-old Caucasian 
woman presents to our center with a 
complaints of fevers recorded as high 
as 104oF, nausea with vomiting, malaise, 
and sore throat. Symptoms had been 
progressive over the course of the prior 
four weeks.  She had been evaluated 
by her primary care provider 10 days 
prior to hospitalization, and had received 
Azithromycin for a diagnosis of left otitis 
media.  
She denies any difficulties with urination 
– no dysuria, flank pain, hematuria, frothy 
urine or change in quantity. Oral intake has 
been maintained.  
The patient is an undergraduate student 
at a local urban university. She resides 
in a rented row home with seven other 
classmates and a cat. She otherwise denies 
any other sick contacts, sexual activity 
or illicit drugs. Medications include oral 
contraceptive pill and a recent Azithromycin 
course.
On physical exam she was noted to have 
a temperature of 40oC and blood pressure 
was 107/75. She had evidence of bilateral 
pharyngeal erythema with pustular, 
exudative lesions. Tender anterior cervical 
lymphadenopathy was present.
Cardiopulmonary examination was positive 
for a regular tachycardia with diffuse and 
scattered bilateral crackles. The edge of the 
liver and tip of the spleen were palpable. 
The remainder of the examination was 
unremarkable.
Figure 2C.
Epstein-Barr Encoded RNA (EBER) positive lymphocyte staining in the 
interstitium.
Acute Epstein Barr virus infection resulting in severe renal impairment is rare and is typically 
characterized by acute tubulointerstial disease.  
Our case contrasts with previously reported cases1 as the majority of lymphocytes in the 
interstitium were CD4+ T-Lymphocytes.  Consistent with prior studies, the glomeruli were 
unremarkable.
Epstein-Barr encoding region (EBER) in situ hybridization is the methodology of choice for the 
detection of the Epstein-Barr virus (EBV) in tissue sections.6
Epstein-Barr Encoding Regions (EBERs) are secreted from EBV-infected cells and are recognized 
by toll-like receptor (TLR)3, leading to induction of type-I Interferons and inflammatory cytokines, 
and subsequent immune activation.7
This case was complicated by evidence of a recent strep infection (elevated ASO titer) but no 
evidence of deposits suggestive of post-infectious glomerulonephritis were noted on electron 
microscopy.  Prior cases of EBV induced renal failure have been preceeded by streptococal 
infection.1 In addition, the patient had a recent/concurrent Mycoplasma infection, and it is unclear 
what role, if any, this had in her renal insufficiency.1
Therapy is supportive, with anecdotal evidence supporting parenteral corticosteroids as well as 
acyclovir to inhibit viral replication.1 
The patient was treated supportively in regard to her renal manifestations, not requiring renal 
replacement therapy.  Corticosteroids were initiated for severe tonsilar swelling, at that time her 
creatinine had already begun down-trending.  She reached a nadir serum creatinine of 0.64mg/dL 
in follow up four months following the acute illness.
This case underscores the spectrum of EBV disease beyond the classic manifestations, the 
difficulty in identifying the specific pathogenesis of the mechanism of renal dysfunction, and the 
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